PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.45%
Revenue growth 1.25-1.5x NXPI's 8.40%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
11.88%
Gross profit growth similar to NXPI's 12.19%. Walter Schloss would assume both firms track common industry trends.
20.05%
EBIT growth below 50% of NXPI's 226.00%. Michael Burry would suspect deeper competitive or cost structure issues.
20.81%
Operating income growth under 50% of NXPI's 226.00%. Michael Burry would be concerned about deeper cost or sales issues.
21.69%
Net income growth under 50% of NXPI's 120.41%. Michael Burry would suspect the firm is falling well behind a key competitor.
22.86%
EPS growth under 50% of NXPI's 113.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
22.33%
Diluted EPS growth under 50% of NXPI's 121.43%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.60%
Share reduction while NXPI is at 0.31%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.69%
Reduced diluted shares while NXPI is at 0.34%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth of 0.00% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
87.79%
OCF growth above 1.5x NXPI's 45.80%. David Dodd would confirm a clear edge in underlying cash generation.
100.52%
FCF growth above 1.5x NXPI's 41.34%. David Dodd would verify if the firm’s strategic investments yield superior returns.
61.16%
10Y revenue/share CAGR 1.25-1.5x NXPI's 40.90%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
38.87%
5Y revenue/share CAGR at 75-90% of NXPI's 49.13%. Bill Ackman would encourage strategies to match competitor’s pace.
26.13%
3Y revenue/share CAGR above 1.5x NXPI's 9.40%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
61.31%
10Y OCF/share CAGR under 50% of NXPI's 901.53%. Michael Burry would worry about a persistent underperformance in cash creation.
63.85%
Below 50% of NXPI's 144.80%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
33.59%
3Y OCF/share CAGR above 1.5x NXPI's 12.46%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
137.49%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
87.46%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
66.91%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
41.50%
Equity/share CAGR of 41.50% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
10.21%
Below 50% of NXPI's 689.17%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.58%
Below 50% of NXPI's 1418.43%. Michael Burry suspects a serious short-term disadvantage in building book value.
522.75%
Dividend/share CAGR of 522.75% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
191.83%
Dividend/share CAGR of 191.83% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.48%
3Y dividend/share CAGR of 66.48% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.28%
AR growth of 7.28% while NXPI is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-2.00%
Inventory is declining while NXPI stands at 2.29%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.99%
Asset growth above 1.5x NXPI's 0.70%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.24%
BV/share growth above 1.5x NXPI's 0.91%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Our R&D shrinks while NXPI invests at 2.89%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.07%
We cut SG&A while NXPI invests at 11.03%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.